查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571672

支氣管切片檢查設備市場規模、佔有率和趨勢分析報告：按產品、按地區、細分市場預測，2024-2030 年

Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

支氣管切片檢查設備市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球支氣管切片檢查設備市場規模將達10.2億美元，2024年至2030年複合年成長率為7.39%。

推動市場成長的主要因素之一是擴大使用支氣管切片檢查設備來診斷呼吸系統疾病以及擴大採用一次性設備。此外，快速的技術進步以及對呼吸系統疾病的意識提升和篩檢的提高也有助於市場的擴張。

醫療技術的進步透過提高診斷程序的準確性、安全性和有效性，顯著推動了市場的成長。 EBUS-TBNA 等創新技術可以更精確地對肺組織進行採樣，尤其是在難以到達的區域。與傳統手術方法相比，這些微創手術可最大限度地減少患者的不適，降低併發症的風險，並縮短恢復時間。此外，公司正帶著技術先進的產品進入市場，以建立強大的影響力。例如，2021年5月，Olympus擴大了產品系列，推出了用於肺癌診斷和分期的支氣管內超音波（EBUS）支氣管鏡BF-UC190F。

此外，各機構主導的意識提升和篩檢工作正在顯著推動對支氣管切片檢查設備的需求。由於肺癌是全球發病率和死亡率最高的癌症之一，美國肺臟協會和世界衛生組織等組織正在加強努力，促進早期發現和診斷。 2024 年 8 月，為紀念世界肺癌日，以全球氣喘計劃為創始成員的國際呼吸學會論壇強調，將提高人們對肺癌的認知，提供早期篩檢並獲得肺癌診斷和治療。

此外，COVID-19 大流行對支氣管切片檢查設備市場產生了中等程度的負面影響，大流行初期觀察到的肺癌診斷和治療中斷證明了這一點。根據Elsevier Espana SLU 2021年7月進行的一項研究，西班牙一家大學醫院因2020年3月23日至6月21日強制隔離，肺癌診斷數量大幅減少。這一減少是由於諮詢、診斷測試和非必要程序的取消和延遲，導致切片檢查和篩檢次數減少。

支氣管切片檢查設備市場報告亮點：

  • 按產品分類，經支氣管針吸活體組織切片 (TBNA) 針細分市場在 2023 年佔據最大收益佔有率，達 62.18%，預計在預測期內將以最高複合年成長率成長。此外，切片檢查設備（冷凍探針）領域預計在預測期內將顯著成長。
  • 2023年，EBUS-TBNA細分市場佔據最大市場佔有率。 EBUS-TBNA 是一種微創技術，因為它可以從肺部和周圍淋巴結中收集組織樣本，而無需進行大手術。
  • 2023年，北美以超過40%的市佔率主導市場。這是由於強大的醫療基礎設施和創新診斷工具的日益採用。
  • 市場上的主要企業正在採取多種策略，包括聯盟、合作和產品發布，以擴大其產品範圍並增加市場佔有率。例如，2024年5月，庫克醫療在美國推出了下一代EchoTip AcuCore內視鏡超音波（EUS）切片穿刺針。它與超音波視鏡結合使用，用於硬膜外和黏膜下病變淋巴結、縱隔腫塊和胃腸道腹膜內腫塊的 FNB。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場威脅分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析
    • COVID-19 影響分析

第4章 產品經營分析

  • 2023年及2030年產品市場佔有率
  • 產品細分儀表板
  • 2018-2030 年按產品分類的市場規模、預測與趨勢分析
  • 切片檢查鉗
    • 支氣管切片檢查鉗市場，耐用性，2018-2030
    • 一次性的
    • 可重複使用的
  • 經支氣管針吸切片 (TBNA) 針
    • 經支氣管針吸活體組織切片 (TBNA) 針市場，2018-2030
    • 傳統的
    • EBUS-TBNA
  • 細胞學刷
    • 細胞學刷市場，2018-2030
  • 冷凍活體組織切片裝置
    • 活體組織切片設備市場，耐用性，2018-2030
    • 一次性的
    • 可重複使用的

第5章 區域估計/趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030年北美支氣管切片檢查設備市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲支氣管切片檢查設備市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030年亞太地區切片檢查設備市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲支氣管切片檢查設備市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲支氣管切片檢查設備市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Medtronic
    • Boston Scientific Corporation
    • Cook Medical
    • CONMED Corporation
    • Telemed Systems, Inc.
    • HOBBS MEDICAL INC
    • Becton, Dickinson and Company（BD）
    • Olympus Corporation
    • Horizons International Corp.
    • Argon Medical Devices
    • Erbe Elektromedizin GmbH
Product Code: GVR-4-68040-126-7

Bronchial Biopsy Devices Market Growth & Trends:

The global bronchial biopsy devices market size is expected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the major factors contributing to the growth of the market is the rising utilization of bronchial biopsy devices for diagnosing respiratory diseases and the increasing adoption of disposable devices. Moreover, rapid technological advancements and increasing awareness and screening regarding respiratory diseases also contribute to market expansion.

Advancements in medical technology are significantly driving the growth of the market by improving the precision, safety, and effectiveness of diagnostic procedures. Innovations such as EBUS-TBNA enable more accurate sampling of lung tissue, especially in difficult-to-reach areas. These minimally invasive techniques minimize patient discomfort, reduce the risk of complications, and shorten recovery times compared to traditional surgical methods. In addition, companies are entering the market with technologically advanced products to establish a strong presence. For instance, in May 2021, Olympus launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for lung cancer diagnosis and staging, thereby expanding its product portfolio.

Moreover, the increasing awareness and screening initiatives led by various organizations are significantly driving the demand for bronchial biopsy devices. With lung cancer being one of the most prevalent and deadly forms of cancer globally, organizations such as the American Lung Association and the WHO have intensified their efforts to promote early detection and diagnosis. In August 2024, in recognition of World Lung Cancer Day, the Forum of International Respiratory Societies, with the Global Initiative for Asthma as a founding member, emphasized the critical need for increased awareness, early screening, and improved access to lung cancer diagnosis & treatment.

Furthermore, the COVID-19 pandemic had a moderately negative impact on the bronchial biopsy device market, as evidenced by the disruption in lung cancer diagnosis and treatment observed during the early months of the pandemic. According to a study conducted by Elsevier Espana SLU, in July 2021, at a referral University Hospital in Spain, the mandatory confinement from March 23rd to June 21st, 2020, led to a substantial decrease in the number of lung cancer diagnoses. This decline was attributed to the cancellation or delay of medical consultations, diagnostic tests, and non-essential procedures, which resulted in a reduced number of lung biopsies & screening visits.

Bronchial Biopsy Devices Market Report Highlights:

  • Based on product, the transbronchial needle aspiration (TBNA) needles segment held the largest revenue share of 62.18% in 2023 and is expected to register growth at the highest CAGR over the forecast period. Moreover, the cryobiopsy devices (cryoprobes) segment is anticipated to grow significantly over the forecast period
  • The EBUS-TBNA segment held the largest market share in 2023, as it is a minimally invasive technique that allows for collecting tissue samples from the lungs and surrounding lymph nodes without requiring major surgery
  • In 2023, North America dominated the market with a share of over 40%, owing to the robust healthcare infrastructure and rising adoption of innovative diagnostic tools
  • Key players in the market are adopting several strategies such as partnership, collaboration, and product launch to expand their offering and increase their market share. For instance, in May 2024, Cook Medical, introduced AcuCore, a next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. It is employed with an ultrasound endoscope for FNB of extramural and submucosal lesions lymph nodes, mediastinal masses, and intraperitoneal masses within the GI tract

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising utilization of bronchial biopsies for diagnosing lung cancer and related conditions
      • 3.2.1.2. Rising adoption of disposable devices
      • 3.2.1.3. Rapid technological advancements
      • 3.2.1.4. Increasing awareness and screening initiatives by organizations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of alternative solutions
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Threat Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Biopsy Forceps
    • 4.4.1. Bronchial biopsy forceps market, by durability, 2018 - 2030 (USD Million)
    • 4.4.2. Disposable
      • 4.4.2.1. Disposable market, 2018 - 2030 (USD Million)
    • 4.4.3. Reusable
      • 4.4.3.1. Disposable market, 2018 - 2030 (USD Million)
  • 4.5. Transbronchial needle aspiration (TBNA) needles
    • 4.5.1. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
    • 4.5.2. Conventional
      • 4.5.2.1. Conventional market, 2018 - 2030 (USD Million)
    • 4.5.3. EBUS-TBNA
      • 4.5.3.1. EBUS-TBNA market, 2018 - 2030 (USD Million)
  • 4.6. Cytology Brushes
    • 4.6.1. Cytology brushes market, 2018 - 2030 (USD Million)
  • 4.7. Cryobiopsy Devices
    • 4.7.1. Cryobiopsy devices market, by durability, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable market, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Disposable market, 2018 - 2030 (USD Million)

Chapter 5. Regional Estimates & Trend Analysis by Component

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key country dynamic
      • 5.4.2.2. Regulatory framework/reimbursement scenario
      • 5.4.2.3. U.S. bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key country dynamic
      • 5.4.3.2. Regulatory framework/reimbursement scenario
      • 5.4.3.3. Canada bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key country dynamic
      • 5.4.4.2. Regulatory framework/reimbursement scenario
      • 5.4.4.3. Mexico bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key country dynamic
      • 5.5.2.2. Regulatory framework/reimbursement scenario
      • 5.5.2.3. UK bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key country dynamic
      • 5.5.3.2. Regulatory framework/reimbursement scenario
      • 5.5.3.3. Germany bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key country dynamic
      • 5.5.4.2. Regulatory framework/reimbursement scenario
      • 5.5.4.3. France bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key country dynamic
      • 5.5.5.2. Regulatory framework/reimbursement scenario
      • 5.5.5.3. Italy bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key country dynamic
      • 5.5.6.2. Regulatory framework/reimbursement scenario
      • 5.5.6.3. Spain bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key country dynamic
      • 5.5.7.2. Regulatory framework/reimbursement scenario
      • 5.5.7.3. Norway bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamic
      • 5.5.8.2. Regulatory framework/reimbursement scenario
      • 5.5.8.3. Denmark bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key country dynamic
      • 5.5.9.2. Regulatory framework/reimbursement scenario
      • 5.5.9.3. Sweden bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key country dynamic
      • 5.6.2.2. Regulatory framework/reimbursement scenario
      • 5.6.2.3. Japan bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key country dynamic
      • 5.6.3.2. Regulatory framework/reimbursement scenario
      • 5.6.3.3. China bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key country dynamic
      • 5.6.4.2. Regulatory framework/reimbursement scenario
      • 5.6.4.3. India bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamic
      • 5.6.5.2. Regulatory framework/reimbursement scenario
      • 5.6.5.3. South Korea bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key country dynamic
      • 5.6.6.2. Regulatory framework/reimbursement scenario
      • 5.6.6.3. Australia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key country dynamic
      • 5.6.7.2. Regulatory framework/reimbursement scenario
      • 5.6.7.3. Thailand bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key country dynamic
      • 5.7.2.2. Regulatory framework/reimbursement scenario
      • 5.7.2.3. Brazil bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key country dynamic
      • 5.7.3.2. Regulatory framework/reimbursement scenario
      • 5.7.3.3. Argentina bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key country dynamic
      • 5.8.2.2. Regulatory framework/reimbursement scenario
      • 5.8.2.3. South Africa bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key country dynamic
      • 5.8.3.2. Regulatory framework/reimbursement scenario
      • 5.8.3.3. Saudi Arabia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key country dynamic
      • 5.8.4.2. Regulatory framework/reimbursement scenario
      • 5.8.4.3. UAE bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key country dynamic
      • 5.8.5.2. Regulatory framework/reimbursement scenario
      • 5.8.5.3. Kuwait bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Medtronic
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Boston Scientific Corporation
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Cook Medical
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. CONMED Corporation
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Telemed Systems, Inc.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. HOBBS MEDICAL INC
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Becton, Dickinson and Company (BD)
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Olympus Corporation
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Horizons International Corp.
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Argon Medical Devices
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Erbe Elektromedizin GmbH
      • 6.5.11.1. Overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 4. North America bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 5. North America bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 6. U.S. bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 7. Canada bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. Mexico bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9. Europe bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10. UK bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11. Germany bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12. France bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 13. Italy bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14. Spain bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15. Norway bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16. Denmark bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. Sweden bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18. Asia Pacific bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 19. Asia Pacific bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20. Japan bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. China bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22. India bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23. Australia bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24. South Korea bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 25. Thailand bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26. Latin America bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 27. Latin America bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28. Brazil bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29. Argentina bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 30. Middle East & Africa bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 31. Middle East & Africa bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 32. South Africa bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33. Saudi Arabia bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34. UAE bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 35. Kuwait bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Information procurement
  • Fig. 3. Primary research pattern
  • Fig. 4. Market research approaches
  • Fig. 5. Value chain-based sizing & forecasting
  • Fig. 6. Market formulation & validation
  • Fig. 7. Market segmentation
  • Fig. 8. Market snapshot
  • Fig. 9. Segment snapshot
  • Fig. 10. Competitive landscape snapshot
  • Fig. 11. Market trends & outlook
  • Fig. 12. PESTLE analysis
  • Fig. 13. Porter's five forces analysis
  • Fig. 14. Bronchial biopsy devices market: Product outlook and key takeaways
  • Fig. 15. Bronchial biopsy devices market: Product movement analysis
  • Fig. 16. Biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 17. Disposable biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 18. Reusable biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 19. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
  • Fig. 20. Conventional market, 2018 - 2030 (USD Million)
  • Fig. 21. EBUS-TBNA market, 2018 - 2030 (USD Million)
  • Fig. 22. Cytology brushes market, 2018 - 2030 (USD Million)
  • Fig. 23. Cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 24. Disposable cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 25. Reusable cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 26. Regional marketplace: Key takeaways
  • Fig. 27. Regional outlook, 2023 & 2030
  • Fig. 28. Bronchial biopsy devices market : Region movement analysis
  • Fig. 29. North America bronchial biopsy devices market , 2018 - 2030 (USD Million)
  • Fig. 30. U.S. bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 31. Key country dynamics
  • Fig. 32. Canada bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 33. Key country dynamics
  • Fig. 34. Mexico bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 35. Key country dynamics
  • Fig. 36. Europe bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 37. UK bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 38. Key country dynamics
  • Fig. 39. Germany bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 40. Key country dynamics
  • Fig. 41. France bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 42. Key country dynamics
  • Fig. 43. Italy bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 44. Key country dynamics
  • Fig. 45. Spain bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 46. Key country dynamics
  • Fig. 47. Spain bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 48. Key country dynamics
  • Fig. 49. Norway bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 50. Key country dynamics
  • Fig. 51. Denmark bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 52. Key country dynamics
  • Fig. 53. Sweden bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 54. Key country dynamics
  • Fig. 55. Asia Pacific bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 56. Japan bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 57. Key country dynamics
  • Fig. 58. China bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 59. Key country dynamics
  • Fig. 60. India bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 61. Key country dynamics
  • Fig. 62. Australia bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 63. Key country dynamics
  • Fig. 64. South Korea bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 65. Key country dynamics
  • Fig. 66. Thailand bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 67. Key country dynamics
  • Fig. 68. Latin America bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 69. Brazil bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 70. Key country dynamics
  • Fig. 71. Argentina bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 72. Key country dynamics
  • Fig. 73. Middle East and Africa bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 74. South Africa bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 75. Key country dynamics
  • Fig. 76. Saudi Arabia bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 77. Key country dynamics
  • Fig. 78. UAE bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 79. Key country dynamics
  • Fig. 80. Kuwait bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 81. Key country dynamics
  • Fig. 82. Company categorization
  • Fig. 83. Strategy mapping
  • Fig. 84. Company market position analysis